Apart from the cell line H1650, Mcl-1 and Bcl-xL inhibition led to clear sensitization effects while Bcl-2 inhibition via ABT-199 played a negligible role in NSCLC cells. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.